Taken together, our study reveals a functional SOX2/GLI1-ST3GAL1-AXL axis in a subgroup of melanomas involved in cancer progression, and highlights the therapeutic potential of targeting ST3GAL1 to prevent or treat metastatic melanoma. Here, AXL is linked to melanoma.